BL Pharmtech Corp. (KOSDAQ: 065170)

BL Pharmtech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,748	10,607	5,024	21,752	12,380	22,722
Short-Term Investments	0	2,600	500	1,000	-	5,000
Cash & Short-Term Investments	4,748	13,207	5,524	22,752	12,380	27,722
Cash Growth	71.34%	139.10%	-75.72%	83.78%	-55.34%	-12.67%
Accounts Receivable	953.05	1,011	9,208	10,364	10,230	4,323
Other Receivables	121.31	72.82	1,863	120.06	24.69	851.59
Receivables	1,081	1,083	11,071	11,097	10,592	5,512
Inventory	1,049	1,893	14,754	7,765	11,209	6,497
Prepaid Expenses	85.35	213.11	353.37	60.02	94.99	85.62
Other Current Assets	523.09	518.21	909.22	627.19	267.68	459.84
Total Current Assets	7,486	16,915	32,612	42,301	34,544	40,277
Property, Plant & Equipment	4,378	2,878	42,339	42,899	48,512	30,123
Long-Term Investments	16,269	22,056	17,011	26,439	15,671	3,608
Goodwill	-	-	8,000	13,151	29,389	5,997
Other Intangible Assets	402.51	548.99	1,170	1,538	1,460	298.85
Long-Term Accounts Receivable	193.6	0	-	-	0	-
Long-Term Deferred Tax Assets	-	-	1,532	1,679	1,492	3,630
Long-Term Deferred Charges	-	-	-	3.94	19.7	35.46
Other Long-Term Assets	13,228	2,403	1,023	2,330	2,937	4,844
Total Assets	42,060	44,802	103,687	130,341	134,325	89,113
Accounts Payable	218.67	1,078	2,845	7,254	5,490	1,334
Accrued Expenses	30.91	62.56	555.77	447.08	570.51	323.3
Short-Term Debt	2,652	1,410	29,092	7,817	12,552	8,684
Current Portion of Long-Term Debt	-	-	1,967	12,804	5,695	-
Current Portion of Leases	416.84	361.19	504.13	422.67	393.36	252.14
Other Current Liabilities	3,324	5,054	14,015	8,255	7,030	6,064
Total Current Liabilities	6,642	7,965	48,979	37,000	31,731	16,658
Long-Term Debt	1,300	2,343	10,739	20,694	24,854	19,331
Long-Term Leases	733.84	148.36	404	156.55	453.17	432.39
Long-Term Deferred Tax Liabilities	227.49	252.17	310.39	360	411.96	-
Other Long-Term Liabilities	2,031	1,787	84.29	3,852	1,581	57.15
Total Liabilities	11,474	13,002	62,604	64,832	61,408	38,217
Common Stock	44,485	44,485	44,485	44,485	43,498	30,953
Additional Paid-In Capital	102,272	101,175	99,995	100,007	92,978	64,345
Retained Earnings	-104,857	-102,983	-95,790	-82,200	-62,070	-44,046
Treasury Stock	-1.69	-1.69	-1.69	-1.69	-1.31	-1.3
Comprehensive Income & Other	-11,615	-11,257	-14,888	-3,794	-8,304	-5,798
Total Common Equity	30,284	31,419	33,800	58,497	66,102	45,453
Minority Interest	301.8	380.35	7,282	7,013	6,815	5,444
Shareholders' Equity	30,586	31,799	41,082	65,510	72,917	50,896
Total Liabilities & Equity	42,060	44,802	103,687	130,341	134,325	89,113
Total Debt	5,102	4,262	42,706	41,894	43,947	28,699
Net Cash (Debt)	-354.74	8,945	-37,182	-19,142	-31,566	-977.14
Net Cash Per Share	-3.98	100.55	-417.92	-218.02	-425.83	-15.81
Filing Date Shares Outstanding	88.97	88.97	88.97	88.97	86.99	61.9
Total Common Shares Outstanding	88.97	88.97	88.97	88.97	86.99	61.9
Working Capital	843.63	8,951	-16,367	5,301	2,813	23,619
Book Value Per Share	340.39	353.15	379.91	657.50	759.84	734.24
Tangible Book Value	29,882	30,870	24,630	43,807	35,252	39,157
Tangible Book Value Per Share	335.87	346.98	276.84	492.39	405.22	632.54
Land	-	1,812	9,553	9,553	11,285	9,552
Buildings	-	1,877	21,726	21,726	23,406	14,437
Machinery	-	396.04	16,835	15,761	15,715	6,586
Construction In Progress	-	-	-	32.85	135.55	320.22

Source: S&P Capital IQ. Standard template. Financial Sources.